8th Annual Johns Hopkins Aramco Healthcare (JHAH)

and Johns Hopkins Medicine International (JHI)

Multidisciplinary Conference

Update in
Comprehensive Cancer Care
January 18-20, 2024 Dhahran, Saudi Arabia

Conference Agenda
Day 1
January 18, 2024, 8 a.m. - 5 p.m.

Time Topic Speaker

8 - 8:20 a.m. Registration

Opening Session: Welcome and Conference Dr. JJ De Gorter &

8:20 - 8:30 a.m.
goals Dr. Nafisah Al Faris

Session 1: Multiple Myeloma

Moderators: Dr. Alaa AlZaki & Dr. Saud Al Subait

First Treatment in Multiple Myeloma in MRD

8:30 -8:50 a.m. Dr. Adil Al Khatti
era
Approach to Relapsed/Refractory Multiple
8:50 - 9:10 a.m. Dr. Omar Abduljalil
Myeloma
Practice Change and Promising New
9:10 - 9:30 a.m. Dr. Saud Alhayli
Therapies in Multiple Myeloma
9:30 - 9:50 a.m. Questions & Discussion

9:50 - 10 a.m. Break

Session 2: Lymphoproliferative Diseases

Moderators: Dr. Hatoon Ezzat & Dr. Alaa Al Zaki

Immunotherapy Strategies in Diffuse Large

10 - 10:20 a.m. Dr. Cole Sterling
B-Cell Lymphoma

Approach to Relapsed/Refractory Hodgkin’s

10:20 - 10:40 a.m. Dr. Mubarak Almansour
Disease
Therapy Selection in Chronic Lymphocytic
10:40 - 11 a.m. Dr. Cole Sterling
Leukemia
Developing a Framework for T-Cell
11 - 11:20 a.m. Dr. Cole Sterling
Lymphomas

11:20 - 11:40 a.m. Questions & Discussion

11:40 a.m. - 12:40

Lunch
p.m.
Day 1
January 18, 2024, 8 a.m. - 5 p.m.

Time Topic Speaker

Session 3: Acute Leukemia
Moderators: Dr. Rami Alsharif & Dr. Basel Abushullaih

Treatment Strategies in ALL: Journey to

12:40 - 1 p.m. Dr. Nahla Shihata
Negative MRD

Current and Emerging Therapies for AML

1 - 1:20 p.m. Dr. Sayed Osman Ahmed
and MDS

1:20 - 1:30 p.m. Questions & Discussion

Session 4: Molecular and Stem Cells New Era

Moderators: Hatoon Ezzat & Dr. Khalid Bakhit
Molecular Role in Risk Stratification and
1:30 – 1:50 p.m. Dr. Khalid Bakhit
Prognosis for Hematological Malignancies
CAR-T Cell Therapy in Hematological
1:50 - 2:10 p.m. Dr. Omar Albanyan
Malignancies
HSCT Complication Management in
2:10 – 2:30 p.m. Dr. Mohsen Alzahrani
Hematological Malignancies
2:30- 2:50 p.m. Thrombosis in cancer patients Dr. Alaa AlZaki

2:50- 3:00 p.m. Questions & Discussion

3:00 - 3:30 p.m. Break

Session 5: Multidisciplinary Team
Moderators: Fatimah Sharrahi & Zainab Abbad
3:30 - 3:50 p.m. Cardiology-Oncology Guidelines Dr. Faisal Alqoofi
Mechanism Underlying the Cross-Talk
3:50 - 4:10 p.m. Dr. Tala Al Talib
Between Heart and Cancer
4:10 - 4:30 p.m. Cancer Patients: The Forgotten Population Dr. Mohammed Habib
New Evidence in Oncology Nutrition to
4:30 -4:50 p.m. Ms. Zainah Ghamdi
Improve Patient Care
4:50 - 5 p.m. Questions & Discussion

Closing Remarks Fatimah Sharrahi

Day 2
January 19, 2024, 8 a.m. - 6 p.m.

Time Topic Speaker

Session 1: Lower GI
Moderators: Dr. Abdulrahman Al Shehri &
Dr. Osama Halaweh
Restructuring Health Care Delivery to
8 - 8:20 a.m. Dr. Russell Hales
Improve Health Outcomes

Colorectal Cancer Neo-Adjuvant Treatment

8:20 - 8:40 a.m. Dr. Marwan Alhejeili
Approach
Targeted and Immunotherapy Treatment
8:40 - 9 a.m. Dr. Mohammed Algarni
Options in Colorectal Cancer
How to Approach Colorectal Cancer
9 - 9:20 a.m. Dr. Waleed Alselwi
Oligometastases

9:20 - 9:40 a.m. Questions & Discussion

9:40 - 9:50 a.m. Break

Session 2: Upper GI
Moderators: Dr. Osama Halaweh & Dr. Waleed Alselwi

Treatment Sequencing and Optimization of

9:50 - 10:10 a.m. Dr. Ahmed Allehebi
Gastric and Junction Advanced GE

Current Landscape of Treatment of

10:10 - 10:30 a.m. Dr. Fahad IbnShamsah
Advanced HCC
Latest Treatment Strategies and Standard of
10:30 - 11:10 a.m. Dr. Samer Abushullaih
Care for Pancreatic Cancer
11:10 - 11:30 a.m. Questions & Discussion
11:30 a.m. - 12:30
Lunch
p.m.
Session 3: Early Breast
Moderators: Dr. Riyadh Al Da’abil &
Dr. Saud Alsbuait
Optimization of Adjuvant Treatment in
12:30 - 12:50 p.m. Dr. Ahmed AlShehri
Locally Advanced ER+ Breast Cancer
Day 2
January 19, 2024, 8 a.m. - 6 p.m.

Time Topic Speaker

Update in Management of Early Triple
12:50 - 1:10 p.m. Dr. Osama Halaweh
Negative Breast Cancer
Treatment of Breast Cancer in Young Adult,
1:10 - 1:30 p.m. Dr. Abdulrahman Alshehri
Special Considerations
1:30 - 1:50 p.m. Questions & Discussion
Session 4: Advanced Breast
Moderators: Dr. Samer Abu Shullaih &
Dr. Saud Al Subait
Treatment Algorithm for Endocrine
1:50 – 2:10 p.m. Sensitive Advanced Hormone Receptor Dr. Meteb Alfoheidi
Positive Breast Cancer
Treatment Sequencing HER2 Positive
2:10 - 2:30 p.m. Dr. Sherif Elsamani
Advanced Breast Cancer
Metastatic Triple Negative Breast Cancer
2:30 - 2:50 p.m. Dr. Ahmed Alwbari
Treatment Update
2:50 - 3:10 p.m. Questions & Discussion

3:10 - 3:30 p.m. Break

Session 5: Multidisciplinary Team
Moderators: Dr. Majed Al Othman &
Dr. Lulua Alrayes
3:30 – 3:50 p.m. Omission Of Axillary Surgery in Breast Cancer Dr. Mohammed Al Zahrani
Management of the Axilla after Neoadjuvant
3:50 – 4:10 p.m. Dr. Lisa Jacobs
Chemotherapy
4:10 – 4:30 p.m. Evolution of Radiation in Breast Cancer Dr. Hanadi Habibullah

4:30 -4:50 p.m. Nodal Management in Melanoma Dr. Lisa Jacobs

4:50 – 5 p.m. Questions & Discussion

Closing Remarks Zainab Abbad

Day 3
January 20, 2024, 8 a.m. - 5 p.m.

Time Topic Speaker

Session 1: Head and Neck
Moderators: Dr. Adnan Al Hebshi & Dr. Abdulaziz Abidi
Management of Acute and Chronic Toxicity
8:20 - 8:40 a.m. of Radiation Therapy in Head and Neck Dr. Anan Bamakhramah
Cancer
The Role of HPV in Prognosis for Head and
8:40 - 9 a.m. Dr. Carole Fakhry
Neck Cancers

9 - 9:20 a.m. Questions & Discussion

9:20 - 9:30 a.m. Break

Session 2: GU
Moderators: Dr. Saud Al Subait & Dr. Tareq Al Tartir

Multimodal Management in Locally

9:30 - 9:50 a.m. Dr. Nirmish Singla
Advanced and Metastatic Kidney Cancer
Multidisciplinary Approaches to Treating
9:50 - 10:10 a.m. Dr. Nirmish Singla
Localized Upper Tract Urothelial Carcinoma
10:10 - 10:20 a.m. Questions & Discussion
Session 3: Prostate
Moderators: Dr. Samer Abushullaih & Dr. Osama Halaweh
Treatment for mCSPC and Multidisciplinary
10:20 - 10:40 a.m. Dr. Abdullah Al Sharm
Management
Treatment Sequencing for Patients with Dr. Abdulraheem
10:40 - 11:00 a.m.
mCRPC Alshangiti
Managing Testicular Cancer: A Stage-Based
11:00 - 11:20 a.m. Dr. Nirmish Singla
Approach
11:20 a.m. - 11:40
Questions & Discussion
p.m.
11:40 - 12:40 p.m. Lunch
Day 3
January 20, 2024, 8 a.m. - 5 p.m.

Time Topic Speaker

Session 4: Lung
Moderators: Dr. Abdulrahman Al Shehri & Dr. Adnan AlHebshi

Can We Cure Metastatic Lung Cancer? A Case

12:40 - 1:00 p.m. Dr. Russell Hales
for Local Therapy in Advanced Stage Disease
Advanced NSCLC Immunotherapy/
1:00 - 1:20 p.m. Checkpoint Inhibitors: Current Clinical Dr. Abdullah Altwairgi
Practice
Role of Molecular Profiling and Targeted
1:20 - 1:40 p.m. Dr. Tuqa Al Khalaf
Treatment in Advanced Lung Cancer
The Transforming Landscape of Stage III
1:40 - 2:00 p.m. Dr. Russell Hales
Lung Cancer Management
2:00 - 2:20 p.m. Role of Radiation Therapy in Stage III NSCLC Dr. Salem Alshehri

2:20 – 2:40 p.m. Questions & Discussion

2:40 - 3:00 p.m. Break

Session 5: Multidisciplinary Team
Moderators: Fatimah Sharrahi & Zainab Abbad
Clinical Respiratory Management for Lung
3:00 - 3:20 p.m. Mr. Abdulaziz Alyami
Cancer Patients
Dr. Mohammed
3:20 - 4:00 p.m. Cancer Pain Management
Abosoudah
Pain Management and Functional Capacity
4:00 - 4:20 p.m. Mr. Osama Al Jeheny
Intervention in PT Cancer Rehabilitation
Managing Common Toxicities Associated
4:20 -4:50 p.m. Dr. Savera Arain
with Immune Checkpoint Inhibitors
4:50 -5:00 p.m. Questions & Discussion
Fatimah Sharrahi &
Closing Remarks
Zainab Abbad